Optiscan Imaging logo

OIL - Optiscan Imaging Share Price

A$0.105 -0.0  -4.6%

Last Trade - 18/09/20

Sector
Healthcare
Size
Micro Cap
Market Cap £28.3m
Enterprise Value £28.6m
Revenue £671k
Position in Universe 970th / 1830
Bullish
Bearish
Unlock OIL Revenue
Momentum
Relative Strength (%)
1m +114.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -19.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.058 0.31 1.35 2.20 1.05 1.19 +82.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Optiscan Imaging Limited revenues increased 13% to A$1.2M. Net loss decreased 25% to A$1.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects R&D Expense - Government Grants increase from A$231K to A$701K (income), Share-based payment expenses decrease of 48% to A$294K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OIL Revenue Unlock OIL Revenue

Net Income

OIL Net Income Unlock OIL Revenue

Normalised EPS

OIL Normalised EPS Unlock OIL Revenue

PE Ratio Range

OIL PE Ratio Range Unlock OIL Revenue

Dividend Yield Range

OIL Dividend Yield Range Unlock OIL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OIL EPS Forecasts Unlock OIL Revenue
Profile Summary

Optiscan Imaging Limited is engaged in the development and commercialization of confocal microscopes. The Company has two business segments: realisation (trading), and research and development. The realization (trading) segment comprises manufacturing and sales of confocal imaging products. The research and development segment's activities include design and development of new products and technologies, including related income from customers. The Company's products are Pentax ISC-1000 and Optiscan FIVE1. Pentax ISC-1000 product has adopted its technology in the management of Barrett's Oesophagus and the prevention of oesophageal adenocarcinoma (Barrett's cancer). The Optiscan FIVE1 is a fluorescence endomicroscope that has been designed for in vivo investigations of animal tissues. The FIVE1 enables a range of animal imaging studies in different organ systems.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated March 11, 1997
Public Since August 8, 1997
No. of Shareholders: n/a
No. of Employees: 8
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 477,778,800
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OIL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OIL
Upcoming Events for OIL
Frequently Asked Questions for Optiscan Imaging
What is the Optiscan Imaging share price?

As of 18/09/20, shares in Optiscan Imaging are trading at A$0.105, giving the company a market capitalisation of £28.3m. This share price information is delayed by 15 minutes.

How has the Optiscan Imaging share price performed this year?

Shares in Optiscan Imaging are currently trading at A$0.105 and the price has moved by 0.169k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Optiscan Imaging price has moved by 0.203k% over the past year.

What are the analyst and broker recommendations for Optiscan Imaging?

There are no analysts currently covering Optiscan Imaging.

When will Optiscan Imaging next release its financial results?

Optiscan Imaging is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Optiscan Imaging dividend yield?

Optiscan Imaging does not currently pay a dividend.

Does Optiscan Imaging pay a dividend?

Optiscan Imaging does not currently pay a dividend.

When does Optiscan Imaging next pay dividends?

Optiscan Imaging does not currently pay a dividend.

How do I buy Optiscan Imaging shares?

To buy shares in Optiscan Imaging you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Optiscan Imaging?

Shares in Optiscan Imaging are currently trading at A$0.105, giving the company a market capitalisation of £28.3m.

Where are Optiscan Imaging shares listed? Where are Optiscan Imaging shares listed?

Here are the trading details for Optiscan Imaging:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: OIL
What kind of share is Optiscan Imaging?

Based on an overall assessment of its quality, value and momentum, Optiscan Imaging is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Optiscan Imaging share price forecast 2020?

We were not able to load any forecast data for Optiscan Imaging.

How can I tell whether the Optiscan Imaging share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Optiscan Imaging. Over the past six months, the relative strength of its shares against the market has been 0.204k%. At the current price of A$0.105, shares in Optiscan Imaging are trading at 0.149k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Optiscan Imaging PE Ratio?

We were not able to find PE ratio data for Optiscan Imaging.

Who are the key directors of Optiscan Imaging?

Optiscan Imaging's management team is headed by:

Michael Corry - CFO
Justin Mouchacca - SEC
Philip Currie - NED
Graeme Mutton - NED
Darren Lurie - CHM
Who are the major shareholders of Optiscan Imaging?

Here are the top five shareholders of Optiscan Imaging based on the size of their shareholding:

Peters Investments Pty. Ltd. Corporation
Percentage owned: 10.15% (48.5m shares)
Ibsen Pty. Ltd. Corporation
Percentage owned: 8.99% (43.0m shares)
Currie (Philip James) Individual Investor
Percentage owned: 3.82% (18.3m shares)
Harech Pty. Ltd. Corporation
Percentage owned: 3.17% (15.2m shares)
Graham (Chris) Individual Investor
Percentage owned: 2.3% (11.0m shares)
Similar to OIL
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.